2018, Number 1
Next >>
Rev Mex Med Transfus 2018; 11 (1)
Coagulopathy and management of hemocomponents in patients with massive transfusion in a university hospital
Cruz CBl, Pérez CF, Cázares TR, Mercado-Del Ángel F
Language: Spanish
References: 12
Page: 5-10
PDF size: 177.93 Kb.
ABSTRACT
Background: Massive hemorrhage causes a mortality of 50% in patients that require massive transfusion. Adequate resuscitation with transfusions during the acute phase increases survival 10 to 15%; however, 25% of patients develop coagulopathy.
Objective: To identify patients with massive transfusions who develop coagulopathy and the relationship with blood products transfused during the acute event.
Material and methods: Data of 90 patients with massive transfusion were collected and patients with criteria of coagulopathy and the blood products transfused were analyzed; likewise, diagnosis on admission, type of lesion, pH, systolic blood pressure, and mortality at 24 hours and 30 days were recorded.
Results: A coagulopathy was identified in 37 patients (18.9%); in this group, a mortality of 71.4% was detected. Patients with a hemoglobin of ‹ 6 g/dL, more prolonged coagulation times, a low pH (≤ 7.25) and who deviated from a packed red cells: fresh frozen plasma: platelet concentration 1:1:1 ratio had a greater mortality at 24 hours.
Conclusions: In our population, one-fifth of patients who require a massive transfusion develop a coagulopathy. A greater risk was found in patients with inadequate transfusion management.
REFERENCES
Kushimoto, S., Kudo, D. & Kawazoe, Y. Acute traumatic coagulopathy and trauma induced coagulopathy: an overview. Journal of Intensive Care. 2017, 5:1-6.
Satoshi Gando, Mineji Hayakawa. Pathophysiology of Trauma-Induced Coagulopathy and Management of Critical Bleeding Requiring Massive Transfusion. Seminars in Thrombosis & Hemostasis. 2016; 42(02): 155-165.
Peng N, Su L. Progresses in understanding trauma-induced coagulopathy and the underlying Review. Chinese Journal of Traumatology. 2017; 20: 133-136.
Rossaint R, Bouillon B, Cerny V, Coats T, Duranteau J, Fernández-Mondéjar E et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016; 20: 1-100.
Curry NS, Davenport RA, Hunt BJ, Stanworth SJ. Transfusion strategies for traumatic coagulopathy. Blood Reviews. 2012; 26: 223-232.
Gando S, Sawamura A, Hayakawa M. Trauma, shock, and disseminated intravascular coagulation. Annals of Surgery. 2011; 254 (1): 10-19.
Mercado-del Angel F, Cazares-Tamez R, Díaz-Olachea C, Pérez-Chavez F. Ratio of hemocomponents in massive transfusion and mortality of trauma patients in a university hospital. Medicina Universitaria. 2014; 16 (65): 161-164.
Etxaniz A, Pita E. Tratamiento de la coagulopatía en la hemorragia del paciente politraumatizado. Rev Esp Anestesiol Reanim. 2015; 63: 289-296.
Jeger V, Zimmermann H, Exadaktylos AK. Can Rapid TEG accelerate the search for coagulopathies in the patient with multiple injuries? J Trauma. 2009; 66 (4): 1253-1257.
McQuilten ZK. Transfusion interventions in critical bleeding requiring massive transfusion: a systematic review. Transfus Med Rev. 2015; 29 (2): 127-137.
Holcomb JB, Fox EE, Zhang X, White N, Wade CE, Cotton BA et al. Cryoprecipitate use in the PROMMTT study. J Trauma Acute Care Surg. 2013; 75 (1 Suppl 1): 531-539.
González BM, Ramírez LE, Cardona ME, Totsuka SS, García BL. Triada mortal en pacientes politraumatizados, relación con mortalidad y severidad. Rev Med Chile. 2013; 141: 1420-1426.